Cargando…
中国慢性髓性白血病患者酪氨酸激酶抑制剂治疗现状的调研:从患者的角度
OBJECTIVE: To assess tyrosine kinase inhibitor (TKI) treatment status in patients with chronic myeloid leukemia (CML) in China and analyze the response-associated factors. METHODS: From May to November in 2014, anonymous questionnaires were distributed to adult CML patients who were receiving TKI tr...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365001/ https://www.ncbi.nlm.nih.gov/pubmed/27535854 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.07.004 |
Ejemplares similares
-
2020年中国慢性髓性白血病患者酪氨酸激酶抑制剂治疗状况调研
Publicado: (2021) -
中国真实世界慢性髓性白血病患者停用酪氨酸激酶抑制剂的观察研究
Publicado: (2022) -
中国服用酪氨酸激酶抑制剂的慢性髓性白血病慢性期患者共存疾病状况及其对患者报告结果的影响
Publicado: (2018) -
慢性髓性白血病患者酪氨酸激酶抑制剂自动停药的多中心回顾性研究
Publicado: (2018) -
慢性髓性白血病患者酪氨酸激酶抑制剂治疗中发生的PH阴性髓系肿瘤
Publicado: (2019)